In October 2016, a Royal Society Theo Murphy International Scientific Meeting on self-assembled peptides was held at Chicheley Hall, Northamptonshire, UK. It featured high profile presentations from leaders in this field who discussed exciting emerging themes in understanding and controlling the self-assembly of peptides to create unique nanostructures with hierarchical order from the atomic scale to micrometre length scales. Many of these peptides have exceptional potential to create novel biofunctional materials and a particular focus of the meeting was on the inter-relationships between nanostructure and bioactivity. The papers collected here represent contributions from many of the invited speakers.
The contribution from Liyanaga et al. [1] describes the notable redoxsensitive aggregation behaviour of molecules incorporating bulky naphthalene diimide motifs with attached amino acids including a non-natural fluorinated phenylalanine derivative. Xu and co-workers [2] have developed remarkable nucleopeptides which are able to bind single-stranded DNA, and facilitate DNA delivery into cells. Obasse et al. [3] have developed modified peptide inhibitors of amyloid fibril formation by the amylin peptide, aggregation of which occurs in type II diabetes. Two N-methylated peptides show very strong aggregation inhibition properties and hence promise in future therapies for this important and increasingly prevalent condition. Basu et al. [4] have developed a fascinating 'ambidextrous' multi-functional peptide derivative which can selectively gel organic solvents even in oil -water mixtures with potential application in oil recovery and waste water treatment. Banerjee & Azevedo [5] have reviewed recent work on synthetic peptides which mimic the triple helical structure of collagen and carefully analyse how to tune the aggregation by careful control of the intermolecular interactions of the peptides. Conticello and co-workers [6] describe their intriguing discovery of a twodimensional sheet-like aggregation motif of collagen-mimetic peptides and discuss this in terms of theoretical models of geometrical frustration. Lee et al. [7] provide a valuable short review of antimicrobial peptides including an advanced new approach using machine learning to relate antimicrobial activity to membrane activity, specifically relating this important bioactivity to the development of membrane curvature. Kong et al. [8] have investigated the kinetics and mechanisms of adsorption of the peptide biosurfactant surfactin (and two synthetic surfactants for comparison) to an oil -water interface generated in a microfluidic device. Remarkable insights into the adsorption process are possible from sophisticated measurements of the type undertaken. Serpell and co-workers [9] contribute a focused short review on 'cross-beta' forming short amyloidogenic peptides, the cross-beta X-ray diffraction pattern being a signature of beta-sheet formation by peptides. Many exemplars from the work of this group are highlighted. Shuguang Zhang [10] provides a personal, partly historical, account of his seminal contributions to the field of self-assembling peptides, especially the design of sequenced peptides and surfactant-like peptides with a range of interesting bioactivities. Finally, the review by Zapadka et al. [11] gives a very valuable new perspective on factors controlling the stability of peptide aggregates, ranging through a variety of physical and chemical influences. This is particularly relevant to the development of therapeutic peptides, as they note.
These papers highlight the remarkable range of innovative research in this fast-moving interdisciplinary field. Many exciting challenges remain as we explore further the interconnections between self-assembly and bioactivity and exploit the understanding of these relationships to create new biofunctional materials. I thank all the contributors, both to the meeting itself and to this theme issue, for their efforts.
